Identification | More | [Name]
2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate maleate | [CAS]
34140-59-5 | [Synonyms]
2-(dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate maleate 2'-PHENYL-2'-DIMETHYLAMINO-N-BUTYL 3,4,5-TRIMETHOXYBENZOATE MALEATE 3,4,5-trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester maleate 3,4,5-TRIMETHOXYBENZOIC ACID 2-(DIMETHYLAMINO)-2-PHENYLBUTYL ESTER MALEATE SALT TRIMEBUTINE MALEATE TRIMEBUTINE MALEATE SALT TRIMEBUTIONE MALEATE 3,4,5-trimethoxy-benzoicacibeta-(dimethylamino)-beta-ethylphenethylester debridat dromostat tm906 [1-ethyl-1-phenyl-2-(3,4,5-trimethoxybenzoyloxy)ethyl]dimethylammonium hydrogen maleate TRIMEBUTINE MALEAT TRIMEBUTINE MALEATE,2'-PHENYL-2'-DIMETHYLAMINO-N-BUTYL3.4.5-TRIMETHOXYBENZOATE MALEATE Cerekinon Digerent Modulon Polibutin Spabucol Transacal | [EINECS(EC#)]
251-845-9 | [Molecular Formula]
C26H33NO9 | [MDL Number]
MFCD00133874 | [Molecular Weight]
503.54 | [MOL File]
34140-59-5.mol |
Chemical Properties | Back Directory | [Appearance]
White Solid | [Melting point ]
122-124°C | [storage temp. ]
2-8°C
| [solubility ]
Slightly soluble in water, soluble in acetonitrile, sparingly soluble in acetone, slightly soluble in ethanol (96 per cent). | [form ]
neat | [color ]
White | [Usage]
Opioid receptor agonist. Antispasmodic | [InChIKey]
FSRLGULMGJGKGI-BTJKTKAUSA-N | [CAS DataBase Reference]
34140-59-5(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
C | [Risk Statements ]
R34:Causes burns. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S27:Take off immediately all contaminated clothing . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . | [WGK Germany ]
2
| [RTECS ]
DI0360000
|
Hazard Information | Back Directory | [Chemical Properties]
White Solid | [Uses]
Trimebutine maleate(34140-59-5) is an antispasmodic that functions as an opioid receptor agonist. Its mechanism of action involves regulating bowel movements and enhancing gastrointestinal function. Trimebutine is commonly used in the treatment of Irritable bowel syndrome. It is also used to restart the movement of the gut after abdominal surgery and to prevent intestinal blockage (paralytic ileus).
| [Definition]
ChEBI: Trimebutine maleate is a trihydroxybenzoic acid. | [Side effects]
Possible side effects of trimebutine may include dry mouth, heartburn, nausea, diarrhea, constipation, drowsiness, dizziness, tiredness, indigestion, or headache. Other less frequent side effects are difficulty urinating, hearing loss, or painful breast enlargement. If any of these symptoms persist or worsen, please inform your doctor or pharmacist immediately. | [References]
https://www.drugs.com/medical-answers/trimebutine-3571789/ Trimebutine: abuse, addiction and overdose https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb8090 |
|
|